Recent trends in the incidence of anxiety and prescription of anxiolytics and hypnotics in children and young people: An e-cohort study

Journal of Affective Disorders

Volumn 183, Issue , 2015, Pages 134-141

  John, A ^a   Marchant, A L ^a   McGregor, J I ^a   Tan, J O A ^a   Hutchings, H A ^a   Kovess, V ^b   Choppin, S ^c   Macleod, J ^d   Dennis, M S ^a   Lloyd, K ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Anxiety; Anxiolytic; Children; Hypnotic; Primary care; Young people

Indexed keywords

ANXIOLYTIC AGENT; DIAZEPAM; HYDROXYZINE; HYPNOTIC AGENT; TEMAZEPAM; ZOPICLONE; HYPNOTIC SEDATIVE AGENT;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; CHILD; COHORT ANALYSIS; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; HYPNOSIS; MAJOR CLINICAL STUDY; MALE; MIXED ANXIETY AND DEPRESSION; PAIN; PANIC; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SLEEP DISORDER; ANXIETY DISORDERS; DISEASE MANAGEMENT; FACTUAL DATABASE; INCIDENCE; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; CHILD; COHORT STUDIES; DATABASES, FACTUAL; DISEASE MANAGEMENT; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INCIDENCE; MALE; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 84929630243     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.05.002     Document Type: Article

References (40)

1. American Psychiatric Association The Diagnostic and Statistical Manual of Mental Disorders: DSM-5 2013 American Psychiatric Publisher Incorporated Washington, DC
2. D.C. Beidel, S.M. Turner, F.R. Sallee, R.T. Ammermann, L.A. Crosby, and S. Pathak SET-C versus fluoxetine in the treatment of childhood social phobia J. Am. Acad. Child Adolesc. Psychiatry 46 12 2007 1622 1632
3. British Medical Association and Royal Pharmaceutical Society of Great Britain British National Formulary 2014 BMJ Books and pharmaceutical press London and Wallingford
4. British Medical Association, NHS Employers Revisions to the GMS Contract 2006/07 2006 British Medical Association London
5. P. Casey, and A. Doherty Adjustment disorder: implications for ICD-11 and DSM-5 Br. J. Psychiatry 201 2 2012 90 92
6. Committee of Safety of Medicines, 2003. Paroxetine (seroxat) - variation assessment report - proposal to contraindicate in adolescents and children under 18 years with major depressive disorder.
7. E.J. Costello, D.L. Foley, and A. Angold 10- Year research update review: the epidemiology of child and adolescent psychiatric disorders: II. Developing epidemiology J. Am. Acad. Child Adolesc. Psychiatry 35 2006 8 2
8. C. Creswell, P. Waite, and P.J. Cooper Assessment and management of anxiety disorders in children and adolescents Arch. Dis. Child. 99 2014 674 678
9. C. Dowrick, and A. Frances Medicalising unhappiness: new classification of depression risks more patients being put on drug treatment from which they will not benefit Br. Med. J. 347 2013 f7140
10. D.V. Ford, K.H. Jones, J.P. Verplancke, R.A. Lyons, G. John, G. Brown, C.J. Brooks, S. Thompson, O. Bodger, T. Couch, and K. Leake The SAIL Databank: building a national architecture for e-health research and evaluation BMC Health Serv. Res. 9 1 2009 157
11. M. Frisher, J. Collins, D. Millson, I. Crome, and P. Croft Prevalence of comorbid psychiatric illness and substance misuse in primary care in England and Wales J. Epidemiol. Community Health 58 12 2004 1036 1041
12. H. Gardarsdottir, E.R. Heerdink, L. Van Dijk, and A.C.G. Egberts Indications for antidepressant drug prescribing in general practice in the Netherlands J. Affect. Disord. 98 1 2007 109 115
13. P. Gaughwin Has the Diagnostic and statistical manual of mental illnesses jumped the shark and is it now time for Australia to reconsider reliance on it Australas. Psychiatry 22 5 2014 470 472
14. John, A., McGregor, J., Fone, D.L., Dunstan, F., Lyons, R.A., Lloyd, K., 2015. Case-finding for common mental disorders (anxiety and depression) in primary care: an external validation of routinely collected data. (Submitted for publication) BMC Health Informatics.
15. R.C. Kessler, P. Berglund, O. Demler, R. Jin, K.R. Merikangas, and E.E. Walters Lifetime prevalence and age of onset distributions of DSM-IV disorders in the national co morbidity survey replication Arch. Gen. Psychiatry 62 6 2005 593 602
16. E. Leray, A. Camara, D. Drapier, F. Riou, N. Bougeant, A. Pelissolo, K.R. Lloyd, V. Bellamy, and B. Millet Prevalence, characteristics and comorbidities of anxiety disorders in France: results from the "Mental Health in General Population" Survey (MHGP) Eur. Psychiatry 26 6 2011 339 345
17. R.A. Lyons, K.H. Jones, G. John, C.J. Brooks, J.P. Verplancke, D.V. Ford, G. Brown, and K. Leake The SAIL databank: linking multiple health and social care datasets BMC Med. Inform. Decis. Mak. 9 1 2009 3 25
18. S. McManus, H. Meltzer, T.S. Brugha, P.E. Bebbington, and R. Jenkins Adult Psychiatric Morbidity in England, 2007: Results of a Household Survey 2009 The NHS Information Centre for Health and Social Care London
19. N. Middleton, D. Gunnell, E. Whitley, D. Dorling, and S. Frankel Secular trends in antidepressant prescribing in the UK, 1975-1998 J. Public Health Med. 23 2001 262 267
20. C. Mitchell, R. Dwyer, T. Hagan, and N. Mathers Impact of the QOF and the NICE guideline in the diagnosis and management of depression: a qualitative study Br. J. Gen. Pract. 61 586 2011 279 289
21. NICE, 2005. Depression in children and young people: identification and management in primary, community and secondary care (CG28). .
22. NICE, 2011. Generalized anxiety disorder and panic disorder (with or without agoraphobia) in adults: management in primary, secondary and community care .
23. NICE, 2013. Social anxiety disorder: recognition, assessment and treatment (CG159). .
24. Office of National Statistics Mental health of children and young people in Great Britain 2004 Palgrave Macmillan Basingstoke
25. M. Olfson, S.C. Marcus, M.M. Weissman, and P.S. Jensen National trends in the use of psychotropic medications by children J. Am. Acad. Child Adolesc. Psychiatry 41 5 2002 514 521
26. V. Patel, A.J. Flisher, S. Hetrick, and P. McGorry Mental health of young people: a global public health challenge Lancet 369 2007 1302 1313
27. POTS, The Pediatric OCD Treatment Study Team Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial J. Am. Med. Assoc. 292 2004 1969 1976
28. G. Rait, K. Walters, M. Griffin, M. Buszewicz, I. Petersen, and I. Nazareth Recent trends in the incidence of recorded depression in primary care Br. J. Psychiatry 195 6 2009 520 524
29. H.J. Ramsawh, R.B. Weisberg, I. Dyck, R. Stout, and M.B. Keller Age of onset, clinical characteristics, and 15-year course of anxiety disorders in a prospective, longitudinal, observational study J. Affect. Disord. 132 1 2011 260 264
30. F. Rani, M.L. Murray, P.J. Byrne, and I.C. Wong Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom Pediatrics 121 5 2008 1002 1009
31. RUPP, The Research Unit on Pediatric Psychopharmacology Anxiety StudyGroup Fluvoxamine for the treatment of anxiety disorders in children and adolescents N. Engl. J. Med. 344 2001 1279 1285
32. J.G. Simeon, and H.B. Ferguson Alprazolam effects in children with anxiety disorders Can. J. Psychiatry 32 7 1987 570 574
33. J.G. Simeon, H.B. Ferguson, and V. Knott Clinical, cognitive,and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders J. Am. Acad. Child Adolesc. Psychiatry 31 1 1992 29 3
34. H.C. Steinhausen, and C. Bisgaard Nationwide time trends in dispensed prescriptions of psychotropic medication for children and adolescents in Denmark Acta Psychiatr. Scand. 129 3 2014 221 231
35. J. Walkup, A. Albano, and J. Piacentini Cognitive behavioural therapy, Sertraline, or a combination in childhood anxiety N. Engl. J. Med. 359 2009 2753 2766
36. K. Walters, G. Rait, M. Griffin, M. Buszewicz, and I. Nazareth Recent trends in incidence of anxiety diagnosis and symptoms in primary care PloS One 7 8 2012 e41670
37. G. Watts Critics attack DSM-5 for over-medicalising normal human behaviour Br. Med. J. 344 2012 e1020
38. Welsh Government, 2010. .
39. Welsh Government, 2013. .
40. L.P.M.M. Wijaars, I. Nazareth, and I. Petersen Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN) PloS One 7 3 2012 e33101